Watton Corey Michael - Net Worth and Insider Trading
Watton Corey Michael Net Worth
The estimated net worth of Watton Corey Michael is at least $15,876 dollars as of 2025-05-19. Watton Corey Michael is the Director of Zevra Therapeutics Inc and owns about 1,800 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $15,876. Details can be seen in Watton Corey Michael's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Watton Corey Michael has not made any transactions after 2025-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Watton Corey Michael
Watton Corey Michael Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Watton Corey Michael owns 1 companies in total, including Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Watton Corey Michael’s form 4 insider trades.
Insider Ownership Summary of Watton Corey Michael
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
ZVRA | Zevra Therapeutics Inc | 2025-03-28 | director |
Watton Corey Michael Latest Holdings Summary
Watton Corey Michael currently owns a total of 1 stock. Watton Corey Michael owns 1,800 shares of Zevra Therapeutics Inc (ZVRA) as of March 28, 2025, with a value of $15,876.
Latest Holdings of Watton Corey Michael
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZVRA | Zevra Therapeutics Inc | 2025-03-28 | 1,800 | 8.82 | 15,876 |
Holding Weightings of Watton Corey Michael
Watton Corey Michael Form 4 Trading Tracker
According to the SEC Form 4 filings, Watton Corey Michael has made a total of 5 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 300 shares on March 28, 2025, which cost Watton Corey Michael around $2,352.
Insider Trading History of Watton Corey Michael
- 1
Watton Corey Michael Trading Performance
GuruFocus tracks the stock performance after each of Watton Corey Michael's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Watton Corey Michael is -3.18%. GuruFocus also compares Watton Corey Michael's trading performance to market benchmark return within the same time period. The performance of stocks bought by Watton Corey Michael within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Watton Corey Michael's insider trading performs compared to the benchmark.
Performance of Watton Corey Michael
Watton Corey Michael Ownership Network
Ownership Network List of Watton Corey Michael
Ownership Network Relation of Watton Corey Michael

Watton Corey Michael Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Watton Corey Michael is the director of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , VP Fin & Corp Controller R. Laduane Clifton , and VP & Corporate Controller Timothy J. Sangiovanni .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Watton Corey Michael made 2 insider transaction in Zevra Therapeutics Inc (ZVRA) with a net purchase of 800. Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 20,000 shares made by John B Bode , a net sale of 9,000 shares made by R. Laduane Clifton , and a net sale of 91,817 shares made by Neil F. Mcfarlane .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 10,300 shares, with a net purchase of 10,300 shares. During the past 18 months, 116,317 shares of Zevra Therapeutics Inc (ZVRA) were sold and 32,800 shares were bought by its insiders, resulting in a net sale of 83,517 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Watton Corey Michael Mailing Address
Above is the net worth, insider trading, and ownership report for Watton Corey Michael. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Watton Corey Michael's mailing address is: Elkhorn Ne 68022.